Intratympanic injection of hydrogel nanodrug for the prevention and treatment of sensorineural hearing loss
- PMID: 37877070
- PMCID: PMC10593563
- DOI: 10.1016/j.joto.2023.09.005
Intratympanic injection of hydrogel nanodrug for the prevention and treatment of sensorineural hearing loss
Abstract
Safe and efficient drug delivery to the inner ear has always been the focus of prevention and treatment of sensorineural deafness. The rapid development of nanodrug delivery systems based on hydrogel has provided a new opportunity. Among them, thermo-sensitive hydrogels promote the development of new dosage form for intratympanic injection. This smart biomaterial could transform to semisolid phase when the temperature increased. Thermo-sensitive hydrogel nanodrug delivery system is expected to achieve safe, efficient, and sustained inner ear drug administration. This article introduces the key techniques and the latest progress in this field.
Keywords: Intratympanic injection; Nanodrug; Sensorineural hearing loss; Thermo-sensitive hydrogel.
© 2023 PLA General Hospital Department of Otolaryngology Head and Neck Surgery. Production and hosting by Elsevier (Singapore) Pte Ltd.
References
-
- Ahmadi N., et al. Long-term effects and potential limits of intratympanic dexamethasone-loaded hydrogels combined with dexamethasone-eluting cochlear electrodes in a low-insertion trauma Guinea pig model. Hear. Res. 2019;384 - PubMed
-
- Borden R.C., et al. Hyaluronic acid hydrogel sustains the delivery of dexamethasone across the round window membrane. Audiol. Neurootol. 2011;16:1–11. - PubMed
-
- Chen K., et al. Adhesive and injectable hydrogel microspheres for inner ear treatment. Small. 2022;18 - PubMed
Publication types
LinkOut - more resources
Full Text Sources